|
|
|
|
| TRADING CENTER |
55.72+1.16 / +2.13%
Teva Pharmaceutical Industries Ltd (NASDAQ GS:TEVA)
Prev. Close:
54.56
Open:
54.66
High:
55.88
Low:
54.35
Volume:
4,001,158
Volume Avg.:
4,654,200
52wk Range:
41.05 - 54.95
Market Cap (mil):
51,354.78
P/E Ratio:
56.86
Dividend Yield:
N/A
| Who Owns Most of the Market? - MotleyFool.com | |
| 9 Cheap Stocks Our Experts Adore - MotleyFool.com | |
| Monday's Biggest Stock Stars - MotleyFool.com | |
| Options Update: Micron Tech Volatility Low; Shares Near 26-month High into EPS - Bloggingstocks.com | |
| OncoGenex Slammed on Teva Parnership: BioBuzz - at TheStreet.com | |
| Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 t... - PR Newswire | |
| Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize ... - Business Wire | |
| Buy a Company, Get the Plant for Free - MotleyFool.com | |
| MDCO Recalls Cleviprex Lots - Analyst Blog - Zacks.com | |
| 3 Stocks in a Tailspin - MotleyFool.com | |
| This Just In: Upgrades and Downgrades - MotleyFool.com | |
| No Holiday Goodwill Twixt Biogen and Facet - MotleyFool.com | |
| 3 Lessons From the Dubai Crisis - MotleyFool.com | |
| Cubist's Acquisition to Add Value - Analyst Blog - Zacks.com | |
| Do You Have What It Takes to Bag a 10-Bagger? - MotleyFool.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 64.50 | 0.17 / 0.27% | 14.08 |
| PFE | Pfizer Inc | 18.61 | -0.00 / -0.01% | 15.64 |
| NVS | Novartis AG | 54.15 | 0.35 / 0.65% | 15.21 |
Short Interest Date:
Nov 30 2009
Short Interest Shares:
9,340,114
Short Interest Ratio:
2.2
Float:
n/a
Short Interest as a % of Float:
n/a
Average Daily Volume:
5,314,200
Outstanding Shares:
912,000,000
Based in Israel, Teva develops, manufactures, and commercializes generic and branded drugs. Teva supplies raw materials to competitors through its bulk pharmaceutical business. On the branded side, Teva produces Copaxone, a multiple sclerosis therapy with annual sales of around $1.7 billion, ... (more)
| 2008 Revenue: | $11.1 B | Headquarters: Petach Tikva, |
| Employees: | 38,307 | CEO: Shlomo Yanai |
| Net Income: | $635.0 M | Industry: Pharmaceuticals |
| Market Cap: | $49.8 B | Website: www.tevapharm.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| TEVA | 55.72 | +1.16 / +2.13% | 54.56 | 55.88 | 54.35 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
